- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07234084
Functional Magnetic Stimulation (FMS) for Bone Marrow Edema in Athletes
The Effectiveness of Functional Magnetic Stimulation in the Physiotherapeutic Rehabilitation of Athletes With Bone Marrow Edema: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Bone marrow edema is a reversible stress-related bone injury in athletes, causing localized pain during loading and confirmed by MRI, the gold standard for diagnosis and monitoring. Grades 2 and 3 of the Fredericson classification represent clinically significant edema without a fracture line and are managed conservatively through physiotherapy including exercise, manual techniques, and gradual reloading. Functional Magnetic Stimulation (FMS) is a non-invasive method that induces deep neuromuscular activation and improves circulation. Although increasingly used in musculoskeletal rehabilitation, its effect on recovery from bone marrow edema has not yet been tested in a controlled clinical setting.
Aim: The aim of the present randomized controlled clinical trial is to evaluate the effectiveness of adding Functional Magnetic Stimulation to a structured physiotherapy rehabilitation program in athletes with MRI-confirmed bone marrow edema of the lower limb. The primary objective is to determine whether the combined approach results in greater clinical improvement, superior functional recovery, and faster radiological resolution of edema compared with physiotherapy alone.
Method: Forty athletes with lower-limb bone marrow edema graded as Fredericson 2 or 3 on MRI will be randomly assigned to two groups. The intervention group will follow a four-week physiotherapy program combining therapeutic exercise, manual therapy, and unloading techniques with Functional Magnetic Stimulation applied twice weekly. The control group will receive the same physiotherapy without FMS. Assessments will occur at baseline, two, four, and sixteen weeks, including pain (NRS 0-10), functional ability (LEFS-GR), and readiness for return to sport (Tegner scale). MRI at baseline, week 4, and week 16 will evaluate Fredericson grade, edema intensity, and edema extent. All parameters are predefined as primary outcomes. Data will be analyzed with mixed-model ANOVA for repeated measures with the significance level set at p < .05.
Expected Results: It is anticipated that athletes receiving Functional Magnetic Stimulation in addition to physiotherapy will show greater pain reduction, improved lower-limb function, faster MRI-documented resolution of bone marrow edema, and earlier readiness to return to sport compared with physiotherapy alone.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Dimitrios Lytras, PhD
- Phone Number: 0030 2310013802
- Email: lytrasde@gmail.com
Study Contact Backup
- Name: Paris Iakovidis, PhD
- Phone Number: 0030 2310013802
- Email: paris_physio@yahoo.com
Study Locations
-
-
Sindos
-
Thessaloniki, Sindos, Greece, 57400
- Recruiting
- Department of Physiotherapy, Faculty of Health Sciences International Hellenic University
-
Contact:
- Dimitrios Lytras, PhD
- Phone Number: 0030 6945713359
- Email: lytrasde@gmail.com
-
Contact:
- Paris Iakovidis, PhD
- Phone Number: 0033 2310013802
- Email: paris_physio@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Athletes aged 18-45 years participating in regular sports training ≥3 sessions per week for the past 6 months.
- MRI-confirmed bone marrow edema (BME) of the lower limb graded as Fredericson 2 or 3.
- Onset of pain or symptoms within the previous 6 weeks.
- Pain intensity ≥4/10 on the Numeric Rating Scale during loading activity.
- Ability to comply with the 4-week intervention and 16-week follow-up assessments.
- Written informed consent provided prior to participation.
Exclusion Criteria:
- Fredericson grade 4 or evidence of a fracture line on MRI. Bone marrow edema secondary to infection, tumor, or systemic inflammatory disease.
- History of recent fracture, surgery, or intra-articular injection in the affected limb within 12 weeks.
- Prior exposure to Functional Magnetic Stimulation or Extracorporeal Shockwave Therapy within 8 weeks before enrollment.
- Presence of metallic implants, pacemaker, or other contraindications to magnetic stimulation.
Pregnancy or breastfeeding. Use of systemic corticosteroids or medications affecting bone metabolism. Any neurological, metabolic, or cardiovascular condition interfering with safe participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Physiotherapy plus Functional Magnetic Stimulation (FMS)
Participants allocated to this group will receive 12 sessions of a conventional physiotherapy protocol and 8 sessions of FMS.
|
Participants will receive a standardized four-week physiotherapy program, three sessions per week (12 sessions in total), each lasting approximately 45 minutes. Treatment will include therapeutic exercise for progressive strengthening and flexibility, manual therapy for pain modulation, and unloading-reloading strategies to restore functional load tolerance. Exercises will be tailored to the recovery stage, and participants will be instructed on home exercises and activity modification. In addition, participants will receive Functional Magnetic Stimulation (FMS) twice weekly for four weeks (eight sessions in total). Each session will last 30 minutes. FMS will be applied directly over the affected region using a fixed frequency of 40 Hz without modulation. The stimulation duty cycle will consist of an active phase of 3 seconds followed by a rest period of 6 seconds. Intensity will be gradually adjusted to patient tolerance avoding scomfort or excessive contraction. |
|
Active Comparator: Physiotherapy without Functional Magnetic Stimulation (FMS)
Participants allocated to this group will receive 12 sessions of a conventional physiotherapy protocol without the FMS
|
Participants in this group will follow the same conventional physiotherapy protocol as the first group, without the application of FMS
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in pain intensity with Numeric Rating Scale (NPRS)
Time Frame: pre-treatment, week 4, Week 16
|
This tool is an eleven-point pain scale numbered from zero to 10.
The left end of the scale corresponds to zero and is marked as "No pain", whereas the right end corresponds to 10 and is marked as "Maximum pain".
Consequently, a higher value indicates more intense pain (Childs et al, 2005).
The examinee is asked to choose an integer that best reflects the intensity of their pain.
Participants will be asked to rate their pain under three conditions: at rest, during standardized loading of the affected limb, and during hypothetical return to sport.The NPRS is widely used to measure pain in both clinical practice and research, showing high test-retest reliability and high conceptual construct validity.
|
pre-treatment, week 4, Week 16
|
|
Changes in lower-limb functional ability with the Greek Version of the Lower Extremity Functional Scale (LEFS-GR)
Time Frame: baseline, week 4, week 16
|
The LEFS-GR is a self-reported questionnaire consisting of 20 items that assess the degree of difficulty in performing everyday and sport-related lower-limb activities.
Each item is rated on a 5-point scale (0 = extreme difficulty or unable to perform; 4 = no difficulty), yielding a total score from 0 to 80, with higher scores indicating better functional ability.
The Greek version of the LEFS has demonstrated excellent internal consistency (Cronbach's α = 0.974) and test-retest reliability (ICC = 0.986, p < 0.001) in individuals with lower-limb musculoskeletal disorders (Stasi et al., 2012).
|
baseline, week 4, week 16
|
|
Changes in bone marrow edema characteristics with Magnetic Resonance Imaging (MRI)
Time Frame: baseline, week 4, week 16
|
Magnetic Resonance Imaging (MRI) will be used to evaluate changes in bone marrow edema (BME) according to the Fredericson classification, which grades stress-related bone injury from 0 (normal) to 4 (cortical fracture).
MRI scans will include T1-weighted and fat-suppressed T2/STIR sequences obtained under identical imaging parameters at all time points.
Semi-quantitative analysis will be performed to record (a) Fredericson grade, (b) bone marrow edema signal intensity on a 0-3 scale, and (c) edema extent as a percentage of the total bone volume.
|
baseline, week 4, week 16
|
|
Changes in return-to-sport readiness with the Tegner Activity Scale and perceived sport pain
Time Frame: baseline, week 4, week 16
|
The Tegner Activity Scale (TAS) is an 11-level ordinal scale designed to evaluate physical activity and sports participation following lower-limb injury.
It ranges from 0 (inability to work or perform daily activities due to symptoms) to 10 (participation in competitive sports at national or elite level).
The validated Greek version (Gr-TAS) demonstrates high internal consistency (Cronbach's α = 0.89) and test-retest reliability (ICC = 0.97) in musculoskeletal populations (Panagopoulos et al., 2020).
In this study, the scale will be combined with a perceived sport-related pain score (NRS 0-10), where higher TAS scores and lower pain scores will indicate greater readiness to return to sport.
|
baseline, week 4, week 16
|
Collaborators and Investigators
Investigators
- Study Chair: Paris Iakovidis, PhD, International Hellenic University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- EC-15/2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Marrow Edema
-
Ellianne M. NasserCompletedBone Marrow EdemaUnited States
-
Zimmer BiometCompletedBone Marrow Edema | Bone Marrow LesionsGermany, Netherlands, Italy, Spain, United Kingdom
-
University of Sao Paulo General HospitalCompletedBone Marrow EdemaBrazil
-
Wuerzburg University HospitalUniversity of Wuerzburg; Crolll GmbhCompletedBone Marrow EdemaGermany
-
Zimmer BiometCompletedBone Marrow EdemaUnited States
-
University of MilanCompleted
-
Istituto Ortopedico RizzoliTerminated
-
University Hospital AugsburgRecruitingFractures, Bone | Bone Marrow EdemaGermany
-
Sohag UniversityRecruiting
Clinical Trials on Conventional Physiotherapy with FMS
-
University of LahoreRecruitingHypotonic Cerebral PalsyPakistan
-
Riphah International UniversityNot yet recruitingAdhesive CapsulitisPakistan
-
King Saud UniversityCompleted
-
University of CadizCompleted
-
University of LahoreCompletedStroke | Subacute StrokePakistan
-
CHU de ReimsTerminatedSubacromial Impingement of the ShoulderFrance
-
Riphah International UniversityCompletedLateral EpicondylitisPakistan
-
Beni-Suef UniversityNot yet recruitingIrritable Bowel SyndromeEgypt
-
Riphah International UniversityCompletedAdhesive CapsulitisPakistan
-
Deraya UniversityNot yet recruitingAdhesive Capsulitis of Shoulder | Frozen Shoulder | Shoulder Pain and StiffnessEgypt